Parkinson's disease - a significant neurological challenge. Current knowledge of etiology, diagnosis and treatment
DOI:
https://doi.org/10.12775/JEHS.2023.35.01.007Keywords
Parkinson's disease, treatment, diagnosisAbstract
Introduction: Parkinson's disease is one of the most common neurodegenerative disorders, affecting several million people worldwide. In the current diagnosis, the most important thing is to watch for individual symptoms, which appear at different stages of the disease and can worsen over time. The wide variation in symptoms may suggest that they are the result of other diseases. It is a disease with an unknown underlying cause, and is incurable.
Aim of the study: Summary of current knowledge regarding diagnosis and treatment of Parkinson's disease.
Material and methods: Review of articles from the PubMed database using the following terms: “Parkinson's disease”, “diagnosis”, “treatment”, “genetics”, “levodopa”, ”α-synuclein”.
Results: The diagnosis of Parkinson's disease is still based on the clinical picture of the patient. In recent years, research has been underway to develop new biomarkers for the disease that would allow faster detection. The treatment used is based on delaying the progression of the disease and its symptoms. Treatment mainly involves levodopa with carbidopa and drugs to reduce the severity of individual symptoms, in some cases surgical methods are used.
Conclusions: Parkinson's disease poses a challenge to doctors because of its unknown cause and incurability. In recent years, a lot of new information has emerged about factors contributing to its onset, such as genetic factors. Treatment, which is mainly based on pharmacotherapy, should be enriched to a greater extent with physical activity adapted by specialists, physiotherapy treatments and also speech exercises, with the aim of making it easier to cope with bothersome symptoms and improve daily life.
References
Radhakrishnan DM, Goyal V. Parkinson's disease: A review. Neurol India. 2018 Mar- Apr;66(Supplement):S26-S35. doi: 10.4103/0028-3886.226451. PMID: 29503325.
Erkkinen MG, Kim MO, Geschwind MD. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a033118. doi: 10.1101/cshperspect.a033118. PMID: 28716886; PMCID: PMC5880171.
Beitz JM. Parkinson's disease: a review. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. PMID: 24389262.
Cerri S, Mus L, Blandini F. Parkinson's Disease in Women and Men: What's the Difference? J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683. PMID: 31282427; PMCID: PMC6700650.
Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020 Feb;36(1):1-12. doi: 10.1016/j.cger.2019.08.002. Epub 2019 Aug 24. PMID: 31733690; PMCID: PMC6905381.
Li T, Le W. Biomarkers for Parkinson's Disease: How Good Are They? Neurosci Bull. 2020 Feb;36(2):183-194. doi: 10.1007/s12264-019-00433-1. Epub 2019 Oct 23. PMID: 31646434; PMCID: PMC6977795.
Du XY, Xie XX, Liu RT. The Role of α-Synuclein Oligomers in Parkinson's Disease. Int J Mol Sci. 2020 Nov 17;21(22):8645. doi: 10.3390/ijms21228645. PMID: 33212758; PMCID: PMC7697105.
Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and Pathogenesis of Parkinson's Syndrome. Annu Rev Pathol. 2023 Jan 24;18:95-121. doi: 10.1146/annurev-pathmechdis-031521-034145. Epub 2022 Sep 13. PMID: 36100231.
Chia SJ, Tan EK, Chao YX. Historical Perspective: Models of Parkinson's Disease. Int J Mol Sci. 2020 Apr 2;21(7):2464. doi: 10.3390/ijms21072464. PMID: 32252301; PMCID: PMC7177377.
Pajares M, I Rojo A, Manda G, Boscá L, Cuadrado A. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications. Cells. 2020 Jul 14;9(7):1687. doi: 10.3390/cells9071687. PMID: 32674367; PMCID: PMC7408280.
Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2. PMID: 33894193; PMCID: PMC8185633.
Stefani A, Högl B. Sleep in Parkinson's disease. Neuropsychopharmacology. 2020 Jan;45(1):121-128. doi: 10.1038/s41386-019-0448-y. Epub 2019 Jun 24. PMID: 31234200; PMCID: PMC6879568.
Weintraub D, Aarsland D, Chaudhuri KR, Dobkin RD, Leentjens AF, Rodriguez-Violante M, Schrag A. The neuropsychiatry of Parkinson's disease: advances and challenges. Lancet Neurol. 2022 Jan;21(1):89-102. doi: 10.1016/S1474-4422(21)00330-6. PMID: 34942142; PMCID: PMC8800169.
Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013 Dec;13(12):409. doi: 10.1007/s11910-013-0409-5. PMID: 24190780; PMCID: PMC4878671.
Isaacson J, Patel S, Torres-Yaghi Y, Pagán F. Sialorrhea in Parkinson's Disease. Toxins (Basel). 2020 Oct 31;12(11):691. doi: 10.3390/toxins12110691. PMID: 33142833; PMCID: PMC7692771.
Waller S, Williams L, Morales-Briceño H, Fung VS. The initial diagnosis and man-agement of Parkinson's disease. Aust J Gen Pract. 2021 Nov;50(11):793-800. doi: 10.31128/AJGP-07-21-6087. PMID: 34713282.
Pagano G, Niccolini F, Politis M. Imaging in Parkinson's disease. Clin Med (Lond). 2016 Aug;16(4):371-5. doi: 10.7861/clinmedicine.16-4-371. PMID: 27481384; PMCID: PMC6280219.
Akdemir ÜÖ, Bora Tokçaer A, Atay LÖ. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders. Turk J Med Sci. 2021 Apr 30;51(2):400-410. doi: 10.3906/sag-2008-253. PMID: 33237660; PMCID: PMC8203173.
Cova I, Priori A. Diagnostic biomarkers for Parkinson's disease at a glance: where are we? J Neural Transm (Vienna). 2018 Oct;125(10):1417-1432. doi: 10.1007/s00702-018-1910-4. Epub 2018 Aug 25. PMID: 30145631; PMCID: PMC6132920.
Radder DLM, Lígia Silva de Lima A, Domingos J, Keus SHJ, van Nimwegen M, Bloem BR, de Vries NM. Physiotherapy in Parkinson's Disease: A Meta-Analysis of Present Treatment Modalities. Neurorehabil Neural Repair. 2020 Oct;34(10):871-880. doi: 10.1177/1545968320952799. Epub 2020 Sep 11. PMID: 32917125; PMCID: PMC7564288.
Church FC. Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease. Biomolecules. 2021 Apr 20;11(4):612. doi: 10.3390/biom11040612. PMID: 33924103; PMCID: PMC8074325.
Tambasco N, Romoli M, Calabresi P. Levodopa in Parkinson's Disease: Current Status and Future Developments. Curr Neuropharmacol. 2018;16(8):1239-1252. doi: 10.2174/1570159X15666170510143821. PMID: 28494719; PMCID: PMC6187751.
Hariz M, Blomstedt P. Deep brain stimulation for Parkinson's disease. J Intern Med. 2022 Nov;292(5):764-778. doi: 10.1111/joim.13541. Epub 2022 Jul 13. PMID: 35798568; PMCID: PMC9796446.
Malek N. Deep Brain Stimulation in Parkinson's Disease. Neurol India. 2019 Jul-Aug;67(4):968-978. doi: 10.4103/0028-3886.266268. PMID: 31512617.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Lucjan Bednarz, Natalia Woś, Kinga Bialic, Artur Bialic, Rafał Bakalarczyk, Paweł Majewski, Karolina Szala-Czerwonka, Karolina Wijas, Adrian Rejmer, Katarzyna Rojek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 712
Number of citations: 0